Health Benefits
Cell and Gene Therapy (CGT): What plan sponsors need to know
After a wave of FDA approvals, annual spending on CGTs is estimated to increase from $5.15 billion in 2020 to $25.3 billion in 2026! What does this mean for your plan?
Read more